Indalpine

DB08953ApprovedWithdrawnSmall molecule

Indalpine was one of the first selective serotonin reuptake inhibitors to reach the American market. It was initially marketed by Pharmuka. However, after the emergence of widespread concern regarding adverse...

Mechanism: Pharmacologically active on Sodium-dependent serotonin transporter
Curator reviewed
Formula / weight: C₁₅H₂₀N₂ · 228.3327 g/mol (avg)
Code names: LM-5008

Resolves to

Compound

UNIIV35562QSVTCAS63758-79-2ChEMBLCHEMBL276520ChEBI134939PubChem44668

Structure

InChIKeySADQVAVFGNTEOD-UHFFFAOYSA-NSMILESC(CC1=CNC2=CC=CC=C12)C1CCNCC1

Targets

P31645SLC6A4

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1,673Drug interactionsStructured to mechanism, not free text

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Indalpine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account